Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells

被引:4
|
作者
Sarabipour, Sarvenaz [1 ,2 ]
Kinghorn, Karina [3 ,4 ]
Quigley, Kaitlyn M. [4 ]
Kovacs-Kasa, Anita [5 ,6 ]
Annex, Brian H. [5 ,6 ]
Bautch, Victoria L. [3 ,4 ,7 ]
Mac Gabhann, Feilim [1 ,2 ]
机构
[1] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[3] Univ N Carolina, Curriculum Cell Biol & Physiol, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
[5] Augusta Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA USA
[6] Augusta Univ, Dept Med, Med Coll Georgia, Augusta, GA USA
[7] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
关键词
GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; RECEPTOR; ENDOSOME; DOMAIN; NEUROPILIN-1; MECHANISMS; VESICLES; PATHWAY; MODEL;
D O I
10.1371/journal.pcbi.1011798
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The vascular endothelial growth factor (VEGF) family of cytokines are key drivers of blood vessel growth and remodeling. These ligands act via multiple VEGF receptors (VEGFR) and co-receptors such as Neuropilin (NRP) expressed on endothelial cells. These membrane-associated receptors are not solely expressed on the cell surface, they move between the surface and intracellular locations, where they can function differently. The location of the receptor alters its ability to 'see' (access and bind to) its ligands, which regulates receptor activation; location also alters receptor exposure to subcellularly localized phosphatases, which regulates its deactivation. Thus, receptors in different subcellular locations initiate different signaling, both in terms of quantity and quality. Similarly, the local levels of co-expression of other receptors alters competition for ligands. Subcellular localization is controlled by intracellular trafficking processes, which thus control VEGFR activity; therefore, to understand VEGFR activity, we must understand receptor trafficking. Here, for the first time, we simultaneously quantify the trafficking of VEGFR1, VEGFR2, and NRP1 on the same cells-specifically human umbilical vein endothelial cells (HUVECs). We build a computational model describing the expression, interaction, and trafficking of these receptors, and use it to simulate cell culture experiments. We use new quantitative experimental data to parameterize the model, which then provides mechanistic insight into the trafficking and localization of this receptor network. We show that VEGFR2 and NRP1 trafficking is not the same on HUVECs as on non-human ECs; and we show that VEGFR1 trafficking is not the same as VEGFR2 trafficking, but rather is faster in both internalization and recycling. As a consequence, the VEGF receptors are not evenly distributed between the cell surface and intracellular locations, with a very low percentage of VEGFR1 being on the cell surface, and high levels of NRP1 on the cell surface. Our findings have implications both for the sensing of extracellular ligands and for the composition of signaling complexes at the cell surface versus inside the cell. Receptors and their ligands are at the heart of cell-to-cell signaling, but can only interact if they are in the same place at the same time. This is controlled in part by expression-only if a cell expresses a receptor can the cell perceive and respond to that ligand. But it is also controlled in part by where in the cell that receptor is. If the receptor is on the cell surface, it may be able to bind extracellular ligands. If inside the cell, e.g. on endosomal vesicles, it may not. Similarly, the intracellular portions of receptors at the cell surface and inside the cell are exposed to different local environments and can initiate different signaling pathways. Therefore, understanding receptor localization and trafficking (how the receptors move within the cell) is an important starting point for understanding receptor function. Here, we use mechanistic computational modeling and quantitative experimental data to define the localization and trafficking of the VEGF receptors, which are key drivers of blood vessel growth and remodeling. We show that these receptors each has different trafficking and patterns of localization, which has significant implications for the differential responses of these receptors to extracellular ligands.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] Investigating NRP1 and VEGFR2 association using number and brightness
    Bell, Keynon
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 56A - 56A
  • [2] Interactions between NRP1 and VEGFR2 molecules in the plasma membrane
    King, Christopher
    Wirth, Daniel
    Workman, Samuel
    Hristova, Kalina
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2018, 1860 (10): : 2118 - 2125
  • [3] VEGF, VEGFR1, and VEGFR2 expression in melanoma
    Mehnert, J. M.
    McCarthy, M. M.
    Aziz, S. A.
    Sznol, M.
    Flaherty, K. T.
    Camp, R. L.
    Rimm, D. L.
    Kluger, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting
    Swati Sharma
    Marcelo Ehrlich
    Manqi Zhang
    Gerard C. Blobe
    Yoav I. Henis
    Communications Biology, 7
  • [5] VEGFR1 and VEGFR2 in Alzheimer's Disease
    Harris, Rachel
    Miners, James Scott
    Allen, Shelley
    Love, Seth
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 741 - 752
  • [6] PIGF/Nrp1/VEGFR1 Axis Is Upregulated In Gestational Trophoblastic Disease
    Hussein, Yaser
    Snuderl, Matija
    Aghajanian, Carol
    Chiang, Sarah
    MODERN PATHOLOGY, 2015, 28 : 291A - 291A
  • [7] NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting
    Sharma, Swati
    Ehrlich, Marcelo
    Zhang, Manqi
    Blobe, Gerard C.
    Henis, Yoav I.
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [8] PIGF/Nrp1/VEGFR1 Axis Is Upregulated In Gestational Trophoblastic Disease
    Hussein, Yaser
    Snuderl, Matija
    Aghajanian, Carol
    Chiang, Sarah
    LABORATORY INVESTIGATION, 2015, 95 : 291A - 291A
  • [9] EXPRESSIONS OF VEGF, VEGFR1, VEGFR2 AND AKT IN PREGESTATIONAL DIABETIC HUMAN PLACENTAS
    Cetinkaya, Busra
    Ozmen, Ash
    Unek, Gozde
    Bulbul, Gul
    Korgun, Emin Turkay
    PLACENTA, 2014, 35 (09) : A31 - A31
  • [10] TNFalpha and IL-1beta Synergically Decrease VEGFR2 and Increase VEGFR1 Protein Expression in Endothelial Cells
    Yan, Xiaocai
    Managlia, Elizabeth
    De Plaen, Isabelle G.
    FASEB JOURNAL, 2017, 31